Dr. Barakat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20201 N Scottsdale Healthcare Dr
Scottsdale, AZ 85255Phone+1 602-613-5473Fax+1 602-613-5474
Summary
- Dr. Mark Barakat is an ophthalmologist in Phoenix, AZ and is affiliated with multiple hospitals in the area, including Canyon Vista Medical Center, Chandler Regional Medical Center, HonorHealth Scottsdale Osborn Medical Center, and HonorHealth Deer Valley Medical Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 13 years. He specializes in retinal disease and is experienced in retina surgery and vitreoretinal disease.
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalResidency, Ophthalmology, 2005 - 2008
Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 2004 - 2005
Perelman School of Medicine at the University of PennsylvaniaClass of 2004
Certifications & Licensure
AZ State Medical License 2010 - 2025
CA State Medical License 2016 - 2025
OH State Medical License 2008 - 2011
PA State Medical License 2004 - 2008- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Publications & Presentations
PubMed
- 42 citationsThe real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results.Arshad M Khanani, Aamir A Aziz, Hannah Khan, Ashwin Gupta, Ohidul Mojumder
Eye. 2023-12-01 - 66 citationsSafety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map.Arshad M. Khanani, Marco A. Zarbin, Mark R. Barakat, Thomas A. Albini, Peter K. Kaiser
JAMA Ophthalmology. 2021-11-24 - 25 citationsSuprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study.Mark R. Barakat, Charles C. Wykoff, Victor H. Gonzalez, Allen Hu, Dennis M. Marcus
Ophthalmology. Retina. 2021-01-01
Press Mentions
Kodiak Sciences to Present at Innovate Retina 2024October 14th, 2024- Clearside Biomedical Announces Positive Data on CLS-AX OASIS Clinical Trial and Use of SCS MicroinjectorFebruary 21st, 2023
- Clearside Biomedical Announces Positive 6-Month Results from OASIS Extension Study with Suprachoroidal CLS-AX (Axitinib Injectable Suspension) in Wet AMDFebruary 2nd, 2023
- Join now to see all
Professional Memberships
- Member
- Fellow
- The Association for Research in Vision and OphthalmologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
